https://pubmed.ncbi.nlm.nih.gov/38127131/ Biliary atresia

Pediatr Surg Int. 2023 Dec 21;40(1):24.
doi: 10.1007/s00383-023-05606-8.

Diagnostic and prognostic value of the gut microbiota and its metabolite butyrate in children with biliary atresia

Xiaodan Xu # 1 2, Yilin Zhao # 1 2, Xueting Wang 1 3, Ruifeng Zhang 1 2, Shaowen Liu 1 2, Rongjuan Sun 1 2, Zhiru Wang 1 2, Liang Ge 2, Yan Sun 2, Shujian Zhang 2, Hui Ma 4, Jianghua Zhan 5
Affiliations expand
PMID: 38127131

DOI: 10.1007/s00383-023-05606-8
Abstract

Purpose: To determine the prevalent microbiological profile of biliary atresia (BA) patients at the time of its occurrence by studying their intestinal flora.

Methods: A total of 118 gut microbiota samples from three groups of 43 BA patients, 33 disease controls (DC) with other cholestatic diseases and 42 healthy controls (HC), were analyzed by deep mining of public data. Subsequently, a total of 23 fecal samples from three groups of clinically collected patients (11 BA, 6 DC and 6 HC) were sequenced for 16S rRNA gene amplification and analyzed for serum butyrate (BU) level by liquid chromatography.

Results: Taxonomic analysis revealed significant differences in the composition of the intestinal microbiota between BA patients and controls, with a reduction in diversity and a higher abundance of Proteobacteria, Streptococcus and Lactobacillus in the BA group. Database and clinical data analyses concluded that Streptococcus/Bacteroides (AUC = 0.9035, 95% CI 0.8347-0.9722, P < 0.0001) or Streptococcus/Eggerthella (AUC = 0.8333, 95% CI 0.6340-1.000, P = 0.027) was the best microbiota to differentiate between BA and DC. Serum butyrate levels were low in the BA and DC groups and differed from the HC group (P = 0.01, P = 0.04). Butyrate levels in BA were negatively correlated with jaundice clearance and cholangitis, but not statistically significant.

Conclusions: Our study reveals changes in the composition of the gut microbiota in BA, especially the butyrate-producing microbiota, and suggests the potential for using gut microbiota as a noninvasive diagnostic benefit for BA. Low levels of serum butyrate in BA may indicate a poor prognosis.